Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Diagnostics 2025, 15, 2126

阐明NTAR/RGR在肺动脉高压（PAH）和慢性血栓栓塞性肺动脉高压（CTEPH）中的临床应用价值。评述Iancu等人发表于《诊断学》（Diagnostics）2025年第15卷第2126页的文章：评估NT-proBNP/白蛋白比值（NTAR）和RDW/eGFR比值（RGR）作为预测肺动脉高压（PAH）和慢性血栓栓塞性肺动脉高压（CTEPH）患者住院时间和死亡率的生物标志物。